Formula Growth’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,989
Closed -$241K 132
2022
Q4
$241K Hold
12,989
0.07% 127
2022
Q3
$205K Hold
12,989
0.06% 125
2022
Q2
$328K Hold
12,989
0.09% 125
2022
Q1
$469K Hold
12,989
0.09% 136
2021
Q4
$995K Hold
12,989
0.18% 117
2021
Q3
$1.25M Hold
12,989
0.18% 124
2021
Q2
$1.39M Hold
12,989
0.19% 123
2021
Q1
$1.16M Sell
12,989
-2,000
-13% -$220K 0.17% 141
2020
Q4
$1.51M Sell
14,989
-5,000
-25% -$373K 0.25% 103
2020
Q3
$977K Sell
19,989
-5,000
-20% -$240K 0.18% 120
2020
Q2
$1.02M Sell
24,989
-2,500
-9% -$71.8K 0.17% 109
2020
Q1
$423K Sell
27,489
-248,000
-90% -$5.21M 0.08% 126
2019
Q4
$6.23M Buy
+275,489
New +$4.52M 0.79% 39

Other funds holding CRNC

Formula Growth's CRNC Position: Q1 2023 in Review

Formula Growth sold out of Cerence (CRNC) in Q1 2023, closing a stake of 12,989 shares — an estimated $241K sold.

Formula Growth first reported a position in CRNC in Q4 2019 and held it in 13 quarters. The position peaked at $6.23M in Q4 2019. 228 funds tracked by Wall St. Rank hold CRNC as of Q1 2023.

  • Formula Growth reported no remaining Cerence position as of Q1 2023 after selling out during the quarter.
  • Formula Growth sold 12,989 Cerence shares in Q1 2023, an estimated $241K.
  • Formula Growth first reported a position in Cerence in Q4 2019 and held it in 13 quarters.
  • Formula Growth's Cerence position peaked at $6.23M in Q4 2019.
  • 228 funds tracked by Wall St. Rank held Cerence as of Q1 2023.

Based on Formula Growth's 13F filing for Q1 2023, filed 12 May 2023.